Eva Hoffmann
Has grant
Professor
Research Interests
Make your next move.
Prepare your application
Review drafts before you send them.
Explore related searches
Recent Grants
Grant: Close
Incidence and molecular mechanisms of paternal causes of human genomic disorders
Open Date: 2024-10-23
Close Date:
Grant: Close
Assessment of efficacy and diagnostic value of whole genome sequencing for women with ovarian dysfunction
Open Date: 2024-10-22
Close Date:
Grant: Open
The Healthy Reproductive Ageing (HERA) Study
Open Date: 2024-09-01
Close Date: 2030-08-31
Grant: Open
Human genetic variation: molecular mechanisms and functional constraints
Open Date: 2023-01-01
Close Date: 2027-12-31
Grant: Close
Genetic regulation of human oocyte aging (RESPOND)
Open Date: 2022-01-01
Close Date: 2025-12-01
Articles (15)
The leading cause of human pregnancy loss is aneuploidy, often tracing to errors in chromosome segregation during female meiosis 1,2 . Although abnormal crossover recombination is known to confer risk for aneuploidy 3,4 , limited data have hindered understanding of the potential shared genetic basis of these key molecular phenotypes. To address this gap, we performed retrospective analysis of pre-implantation genetic testing data from 139,416 in vitro fertilized embryos from 22,850 sets of biological parents. By tracing transmission of haplotypes, we identified 3,809,412 crossovers, as well as 92,485 aneuploid chromosomes. Counts of crossovers were lower in aneuploid versus euploid embryos, consistent with their role in chromosome pairing and segregation. Our analyses further revealed that a common haplotype spanning the meiotic cohesin SMC1B is associated significantly with both crossover count and maternal meiotic aneuploidy, with evidence supporting a non-coding cis -regulatory mechanism. Transcriptome- and phenome-wide association tests also implicated variation in the synaptonemal complex component C14orf39 and crossover-regulating ubiquitin ligases CCNB1IP1 and RNF212 in meiotic aneuploidy risk. More broadly, variants associated with aneuploidy often showed secondary associations with recombination, and several also exhibited associations with reproductive ageing traits. Our findings highlight the dual role of recombination in generating genetic diversity, while ensuring meiotic fidelity.
Year:
2026
Year:
2026
Pathogenic variants in FANCM have been implicated in premature ovarian insufficiency, suggesting a critical role for FANCM in early germline development. To investigate this gene’s function in a controlled system, we evaluated whether a mouse in vitro primordial germ cell (PGC) model could be used to interrogate the consequences of FANCM loss on germ cell specification. Using CRISPR-Cas9 gene editing, we introduced a premature stop codon into exon 1 of Fancm in mouse embryonic stem cells. These edited cells were differentiated into epiblast-like cells and subsequently into primordial germ cell-like cells (PGCLCs), which were assessed for their developmental competence. After successful generation of in vitro -derived PGCLCs, we found that loss of FANCM markedly reduced PGCLC formation, consistent with previously reported in vivo phenotypes. Our findings demonstrate that this in vitro system provides a tractable platform for dissecting gene function in otherwise inaccessible stages of germline development. Moreover, our data suggest that FANCM is required at the earliest stages of PGC specification, potentially as early as the developmental window equivalent to embryonic day 8.5, a period not previously examined in vivo .
Year:
2026
Year:
2025
Passive maternal-fetal transfer of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) antibodies has been demonstrated, whilst the degree of transfer depending on the trimester of infection is lacking. Due to neonates’ immature immune systems, this knowledge could be of interest when investigating the degree of early-life protection against SARS-CoV-2. For perinatal infections such as Rubella and Toxoplasmosis, the timing of infection related to gestational age is crucial for the severity of maternal-fetal outcomes; hence, the trimester of SARS-CoV-2 infection could potentially be crucial. So far, there is no stratification on all three trimesters of SARS-CoV-2 infection in relation to maternal antibody levels in SARS-CoV-2 positive women, and the degree of transfer of SARS-CoV-2 antibodies to the newborn nor on obstetric and neonatal outcomes, which we examined in this study. Eleven departments in Denmark invited women who tested SARS-CoV-2 positive during pregnancy to participate with a blood sample and a cord blood sample at delivery. 459 SARS-CoV-2 positive women and 2567 SARS-CoV-2 negative women were included. A percentage of 87.5%, 95.3%, and 60.3% of newborns of women who tested positive in their first, second, and third trimester, respectively, had a significantly higher immunoglobin G (IgG) antibody level than their mother at delivery, indicating that the fetus is able to concentrate antibody levels or maintain the level of IgG antibodies transferred. None of the examined maternal-fetal outcomes were increased in women infected with SARS-CoV-2.
Year:
2025
The Danish Monozygotic Twin Study on Migraine is a population-based twin study established in 2023–2024. The cohort was created to lay the foundation for innovative studies of the role of environmental, genetic, and epigenetic factors and their complex interactions in the pathogenesis of migraine. The aim of this paper is to describe data collection, content, characteristics of participants and to assess the representativeness of the cohort by comparing participants to non-responders. Danish monozygotic twins born between 1967 and 2000 were invited to participate. Self-reported questionnaires were sent out to 9,036 possible participants. The questionnaires assessed migraine and migraine subtypes, life satisfaction, resilience, stress, childhood trauma and the relationship of the participant to their family. Through linkage to the nationwide Danish registries the cohort contains individual level information on education, income, patient data from hospitals, prescription medication and childbirth. The Danish registries also enable longitudinal data collection on health outcomes. Individuals who responded to the migraine questionnaire were defined as participants. The cohort consists of 3,893 individuals, including 1,822 complete twin pairs, 1,173 individuals with migraine and 280 migraine discordant twin pairs. 123 participants were included in a substudy with a migraine diagnostic interview and collection of blood samples for both genetic and epigenetic studies. Comparison between participants and non-responders showed a higher participation rate among women. For both genders participants were older, had a higher level of education and a higher level of income compared to non-responders. Sociodemographic differences in participation should be considered to avoid biased estimates in future studies based on the cohort.
Year:
2025
Menopause not only signifies the end of a woman’s reproductive life, but also brings about significant changes in both mental and physical health due to hormonal changes. Age of natural menopause (ANM) and reproductive lifespan is determined by the formation and subsequent depletion of follicles in females. In this study, we identified a robust association between a common functional missense variant in PARP1 and age at menopause in a sample of 201,323 women. Using an in vitro model to generate primordial germ cells - the precursors of sperm and oocytes- we report that Parp1 affects PGCs in two different ways. Our identified missense variant (V762A) significantly reduces the germ cell population by enhanced DNA binding resulting in increased apoptosis. Conversely, deletion of Parp1 results in an increased population of PGCs and proteomic analysis revealed that transcription factors that drive PGC formation show increased expression in precursor cells. This is caused by increased transcription of Rhox genes ( Rhox2A , Rhox6 and Rhox9 ), implicating Parp1 in downregulation of genes that determine PGC fate. We propose that Parp1 regulates PGC fate and that its increased chromatin association (‘trapping’) causes a decreased population of PGCs, thereby providing a molecular cause of the earlier onset menopause on female carriers of the variant.
Year:
2025
The leading cause of human pregnancy loss is aneuploidy, often tracing to errors in chromosome segregation during female meiosis. While abnormal crossover recombination is known to confer risk for aneuploidy, limited data have hindered understanding of the potential shared genetic basis of these key molecular phenotypes. To address this gap, we performed retrospective analysis of preimplantation genetic testing data from 139,416 in vitro fertilized embryos from 22,850 sets of biological parents. By tracing transmission of haplotypes, we identified 3,656,198 crossovers, as well as 92,485 aneuploid chromosomes. Counts of crossovers were lower in aneuploid versus euploid embryos, consistent with their role in chromosome pairing and segregation. Our analyses further revealed that a common haplotype spanning the meiotic cohesin SMC1B is significantly associated with both crossover count and maternal meiotic aneuploidy, with evidence supporting a non-coding cis -regulatory mechanism. Transcriptome- and phenome-wide association tests also implicated variation in the synaptonemal complex component C14orf39 and crossover-regulating ubiquitin ligases CCNB1IP1 and RNF212 in meiotic aneuploidy risk. More broadly, recombination and aneuploidy possess a partially shared genetic basis that also overlaps with reproductive aging traits. Our findings highlight the dual role of recombination in generating genetic diversity, while ensuring meiotic fidelity.
Year:
2025
Triploid and haploid conceptions are not viable and are a common occurrence in humans, where they account for 10% of all pregnancy losses. Despite the parent-of-origin being important in the etiology of the pregnancy, our knowledge of their causes is limited, especially at the point of conception. Using a dataset of 96,660 biopsies and a validation dataset of 44,324 from human blastocysts embryos generated by intra-cytoplasmic sperm injection (ICSI), we estimate that 1.1% of human conceptions (n=1,063) contain extra or missing chromosome sets in zygotes. We identify a maternal age effect, with a 1.059 per year increased risk in triploidy/haploidy (p=0.0008). In 0.03% of couples, we identified three or more triploid/haploid embryos, suggesting a personal risk effect (p=0.03). Genotype analysis of 55 triploid embryo biopsies and their parents show that one third of maternal triploid conceptions originate in meiosis I and two thirds in meiosis II. Seven of these embryos are inferred to have entirely failed to initiate meiotic recombination genome-wide, suggesting that human oocytes with pervasive meiotic recombination failure that are formed during fetal development are capable of ovulation in adult life. Finally, we identify a new type of genome-wide maternal isodiploidy (two maternal chromosome sets) in 0.05% of embryos (41 of 74,009). Collectively, our findings shed light on the biology of meiosis and the formation of human oocytes with the number of chromosome sets.
Year:
2025
Year:
2024
Year:
2024
Year:
2024
Year:
2023
Year:
2023
Year:
2023
Collaborators (46)
Finn Stener Jørgensen
Copenhagen University Hospital
Henrik Løvendahl Jørgensen
Clinical professor, MD, PhD
Copenhagen University Hospital
Javier Martin-Gonzalez
Københavns Universitet
Katharina Maria Main
Faculty of Health and Medical Sciences, University of Copenhagen
Søren Brunak
Professor of Disease Systems Biology, Research Director
Københavns Universitet
anne sørensen
Aalborg University
Rajiv McCoy
Associate Professor
Johns Hopkins University
Kaare Christensen
University of Southern Denmark
Richard Farlie
Aarhus University
Karina Banasik
Associate Professor
Technical University of Denmark
Jennifer Gruhn
Assistant Professor
University of Copenhagen
Iben Sundtoft
VIP, Clinical Associate Professor
Aarhus University
Sisse Rye Ostrowski
Københavns Universitet
Nina la Cour Freiesleben
Head of The Fertility Clinic/Chief Physician, MD PhD, Associate Professor
Hvidovre Hospital
Jesper Olsen
Professor
University of Copenhagen
Anna Aabakke
Consultant, Associate Clinical Professor
-
Laufey Tryggvadottir
Professor
University of Iceland
Margaret Starostik
National Institutes of Health
John Richard Perry
Chair of Molecular Endocrinology
University of Cambridge
David Westergaard
Associate Professor
Technical University of Denmark
Rikke Beck Jensen
Professor
Københavns Universitet
Pia R. Kamstrup
Københavns Universitet
Anja Pinborg
Professor
Rigshospitalet
Peter Loof Møller
Aalborg University
H S Nielsen
Professor
Copenhagen University Hospital
Kari Stefansson
Professor
University of Iceland
Kathleen R. Stewart-Morgan
Københavns Universitet
Per Lav Madsen
Research Associate Professor
University of Copenhagen
Christian Erikstrup
Chair Professor
Aarhus University
Mads Lerdrup
Associate Professor
Københavns Universitet
Mette Nyegaard
Head of Department
Aalborg University
Line Rode
-
Ásgeir Haraldsson
-
Richard Schultz
University of Pennsylvania
Amy Kaucher
Københavns Universitet
Thomas Folkmann Hansen
Professor
Technical University of Denmark
Jens Sønksen
-
Palle Duun Rohde
Associate Professor
Aalborg University
Anne Zedeler
Copenhagen University Hospital
Anna Murray
Professor of Human Genetics
University of Exeter
Gorm Greisen
Københavns Universitet
Claus Yding Andersen
Professor
University of Copenhagen
Ole Birger Pedersen
Professor
Zealand University Hospital
N Jørgensen
-
Lone Schmidt
Professor wsr
Københavns Universitet
Aleksander Giwercman
-
Make your next move.
Prepare your application
Review drafts before you send them.